Get started
Author

Jason Ostergaard

Observed names: Jason Ostergard, Jason P. Ostergaard
OpenAlex ID: A5033857154
Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors
2019 · Pauline J. Beckmann, Jon D. Larson, et al. · Cancer Research · 50
PDF
A novel method to characterize silica bodies in grasses
2016 · Clemon Dabney, Jason Ostergaard, et al. · Plant Methods · 31
PDF
The translational repressor 4E-BP1 regulates RRM2 levels and functions as a tumor suppressor in Ewing sarcoma tumors
2020 · Kelli L. Goss, Stacia L. Koppenhafer, et al. · Oncogene · 28
CXCR4 antagonists disrupt leukaemia‐meningeal cell adhesion and attenuate chemoresistance
2022 · Leslie M. Jonart, Jason Ostergaard, et al. · British Journal of Haematology · 13
PDF
CD99 antibody disrupts T-cell acute lymphoblastic leukemia adhesion to meningeal cells and attenuates chemoresistance
2021 · Maryam Ebadi, Leslie M. Jonart, et al. · Scientific Reports · 10
PDF
Inhibitor of DNA binding 2 (ID2) regulates the expression of developmental genes and tumorigenesis in ewing sarcoma
2022 · Stacia L. Koppenhafer, Kelli L. Goss, et al. · Oncogene · 9
Hypoxanthine in the microenvironment can enable thiopurine resistance in acute lymphoblastic leukemia
2024 · Xiaohong Wang, Jason Ostergaard, et al. · Frontiers in Oncology · 3
PDF
Preclinical efficacy of prexasertib in acute lymphoblastic leukemia
2021 · Jason Ostergaard, Leslie M. Jonart, et al. · British Journal of Haematology · 3
An antibody-drug conjugate targeting VpreB1 for the treatment of B-cell acute lymphoblastic leukemia
2025 · Peter M. Gordon, Robin L. Williams, et al. · Blood Neoplasia · 1
Single-Chain Nanobody Inhibition of Notch and Avidity Enhancement Utilizing the β-Pore-Forming Toxin Aerolysin
2025 · Andrew C. D. Lemmex, Jeremy Allred, et al. · ACS Chemical Biology · 1
Cerebrospinal fluid attenuates the efficacy of methotrexate against acute lymphoblastic leukemia cells
2024 · Jongseok Kang, Jason Ostergaard, et al. · Blood Neoplasia · 1
A Novel Antibody-Drug Conjugate Targeting the CD179a Component of the Surrogate Light Chain for the Treatment of B-Cell Acute Lymphoblastic Leukemia/Lymphoma
2024 · Peter Gordon, Robin Williams, et al. · Blood · 1
ABCB1-Mediated Drug Efflux Drives Resistance to VpreB1-Targeted Antibody-Drug Conjugates in B-cell Lymphoblastic Leukemia
2026 · Robin L. Williams, Xiaohong Wang, et al. · Research Square
PDF
ABCB1-Mediated Drug Efflux Drives Resistance to VpreB1-Targeted Antibody-Drug Conjugates in B-cell Lymphoblastic Leukemia
2026 · Robin L. Williams, Xiaohong Wang, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
IMMU-55. Cerebrospinal fluid reduces the efficacy of T cell responses in vitro to leukemia-targeting immunotherapy
2025 · Robin Williams, Madison Gohman, et al. · Neuro-Oncology
PDF
Cerebral spinal fluid impairs peripheral blood T cell response to stimulation with bispecific T cell engagers against leukemia 4526
2025 · Robin L. Williams, Madison Gohman, et al. · The Journal of Immunology
PDF
Cerebral Spinal Fluid Attenuates the Efficacy of Methotrexate Against Acute Lymphoblastic Leukemia Cells
2023 · Jay Kang, Jason Ostergaard, et al. · Blood
PDF
A Novel Antibody-Drug Conjugate Directed Towards the Surrogate Light Chain of Malignantly-Transformed B-Cell Precursors Reverses Leukemic Progression in NSG Mice
2022 · Peter M. Gordon, Jason Ostergaard, et al. · Blood
Csig-37. Foxr2 Stabilizes Myc and Activates Fak/src Signaling in a Dual Mechanism to Promote Transformation in Neural Progenitor Cells
2018 · Pauline Beckmann, Jon Larson, et al. · Neuro-Oncology
PDF
Works count: 19
Citation count: 151
H-index: 6
I10-index: 5
Year
Topic
Type